Feasibility Study: The Contribution of Hypnosis in the Management of Adults With Brain Injuries
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE · Feb 4, 2025
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years or older;
- • Acquired brain injury of the type stroke (AVC) or traumatic brain injury (TBI), regardless of the severity;
- • Presence of complaints of anxiety, sleep disorders, disabling pain, and/or behavioral disturbances;
- • Stability of medication treatment during the month prior to inclusion.
- Exclusion Criteria:
- • Patients already receiving hypnosis treatment or practicing hypnosis. Patients with prior experience with hypnosis before the injury may be included;
- • Patients presenting or who have presented with aphasia;
- • Patients still experiencing post-traumatic confusion;
- • Patients with a history of psychiatric disorders;
- • History of alcoholism or drug addiction.
About Centre Hospitalier Universitaire De Liege
The Centre Hospitalier Universitaire de Liège (CHU Liège) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, CHU Liège integrates cutting-edge scientific inquiry with clinical practice, fostering an environment that enhances the development of new therapies and medical interventions. With a multidisciplinary team of experienced researchers and healthcare professionals, the institution is dedicated to improving patient outcomes and contributing to the global body of medical knowledge. CHU Liège emphasizes collaboration with industry partners and academic institutions to drive excellence in clinical research and support the translation of findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tinlot, Liège, Belgium
Tinlot, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported